SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE772.052.35 (+0.31 %)
PREV CLOSE ( ) 769.70
OPEN PRICE ( ) 770.00
BID PRICE (QTY) 772.05 (53)
OFFER PRICE (QTY) 772.55 (85)
VOLUME 3447
TODAY'S LOW / HIGH ( )770.00 774.15
52 WK LOW / HIGH ( )452.6 804.4
NSE771.451 (+0.13 %)
PREV CLOSE( ) 770.45
OPEN PRICE ( ) 771.45
BID PRICE (QTY) 771.45 (377)
OFFER PRICE (QTY) 772.40 (11)
VOLUME 4470
TODAY'S LOW / HIGH( ) 771.45 771.45
52 WK LOW / HIGH ( )452.25 804.35
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Sep Announcement under Regulation 30 (LOD
Sanction of Scheme of Amalgamation and Merger of Sun Pharma Global FZE w..
08Sep Sun Pharma forays into nutrition bar s
Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industr..
08Sep Sun Pharma surges on foraying into nut
Sun Pharmaceutical Industries is currently trading at Rs. 774.60, up by..
02Sep Sun Pharmaceutical sells step-down sub
Sun Pharmaceutical Industries has sold Kayaku Co., a wholly-owned subsid..
02Sep Sun Pharmaceutical rises on selling st
Sun Pharmaceutical Industries is currently trading at Rs. 791.45, up by..
Financials
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit4192.9999999999921397
Gross Profit 4326.49999999999 21528.7
Operating Profit 6892.8999999999930862.2
Net Sales 33259.5128032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 21250.00 (0.29%)
M.Cap (Rs. in Cr)45025.46
Astrazeneca Pharma I (BSE)
 3134.60 (1.64%)
M.Cap (Rs. in Cr)7710.00
Piramal Enterprises (BSE)
 2808.15 (1.29%)
M.Cap (Rs. in Cr)66165.91
Procter&Gamble Healt (BSE)
 5410.00 (0.53%)
M.Cap (Rs. in Cr)8933.04
Gland Pharma (BSE)
 3872.45 (0.65%)
M.Cap (Rs. in Cr)63188.61
Shareholding Pattern
PROMOTERS 54.48%
NON-INSTITUTION 12.05%
MUTUAL FUNDS/UTI 12.03%
FI/BANKS/INSURANCE 9.91%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2021 NNM Securities.com

Our Digital Marketing Partner: Public Media Solution

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.